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ABSTRACT 
 
The aim of the present study was to evaluate the chemical composition and bioactivity of Uvariopsis congensis 
Robyns & Ghesq. stem bark extract against Sickle cell disease and associated bacteria. This plant species 
ingested by wild chimpanzees as medicinal food could inhibit the human hemoglobin S polymerization inducing 
hemolysis of sickle erythrocytes (as it does by inhibiting the Plasmodium falciparum inducing hemolysis of 
infected erythrocytes in great apes). The antisickling and antibacterial activities were assessed according 
respectively to Emmel and micro-dilution methods. The results revealed that Uvariopsis congensis Robyns & 
Ghesq. stem bark extract contains various secondary metabolites such as alkaloids, saponins, total polyphenols 
(87.942±0.536 µg GAE/g), flavonoids (0.623±0.630 µg QE/g), tannins (0889±0.002 µg TAE/g), anthocyanis 
(0.150±0.017 µg M-3GE/g), leuco-anthocyanins, quinones, terpenes and steroids. Ethanolic extract displayed 
interesting antisickling activity which was confirmed by the appearance of radius, the increase of the cell area 
and the decrease of it perimeter (p<0.05). The antisickling activity of Uvariopsis congensis Robyns & Ghesq. 
stem bark extract is dose dependent. The minimal concentration of normalization (MCN) and the dose of 
extract for which 50% of the sickled erythrocytes are reversed (ED50) were 100 µg/mL and 0.6 µg/ml 
respectively. The minimum inhibitory concentrations (MIC) were 250 µg/mL and 500 µg/mL respectively for 
Escherichia coli ATCC 27195 and Staphylococcus aureus ATCC 33591. The bioactivity of this plant species 
could be improved by liquid-liquid extraction and chromatographic bio-guided fractionation of ethanolic extract. 
This study validates for the first time the in vitro antisickling activity of Uvariopsis congensis Robyns & Ghesq. 
stem bark extract. The animal self-medication constitutes thus an innovative method which could lead to the 
discovery of new drugs for the treatment of human ailments like Sickle cell disease. 
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Introduction 
Infectious diseases are recognized to 
affect the behavior and reproductive fitness of all 
animals.1 As response, the animal kingdom 
developed anti-parasitic behaviors through plant-
animal co-evolution relationships in which some 
animal phylum utilize the chemical defenses of 
plants to protect themselves from their own 
parasites.2  
In African tropical forests like Congo 
basin, Great apes (GAs) were reported as a good 
model for the understanding of malaria infection 
patho-physiology. Indeed, Humans and great apes 
(bonobos, chimpanzees, gorillas, etc.) share a 
common gut anatomy. Although, some diseases 
that cause countless deaths in humans (like 
malaria) are ineffective or have minor non 
disturbing effects in GAs. These animals adopt a 
self medicative behavior when they are displaying 
malaria symptoms by selecting specific plants for 
controlling parasite infection while this one cause 
hemolytic anemia of human red blood cells.3, 4  
In this regards, we recently hypothesized 
that these plant items could therefore protect 
human sickle erythrocyte against hemolysis (by 
inhibiting the polymerization of sickle hemoglobin 
and radical oxygen species formation within sickle 
erythrocyte) as it does for Plasmodium falciparum 
infected erythrocytes in great apes.5, 6 So, some of 
such plant species occasionally ingested by GAs 
for their supposed medicinal properties were 
reported to contain natural product compounds 
that prevent the erythrocytes hemolysis through 
the inhibition of sickle erythrocyte sickling and 
this bioactivity was scientifically validated.6-11 
Uvariopsis congensis is a shrub or small 
tree. The flowers are solitary and borne in the axils 
of the leaves and on the older wood. The leaf is 
smaller, long by 2 to 6 cm, broad and is elliptic 
instead of oblong to oblanceolate and entirely 
glabrous. The flowers and fruits are very shortly 
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pedunculate; the petals ovate and sub-acute 
(instead of rotund). The fruits are pinkish red in 
color, about 1·5 cm diameter and constricted 
between the seeds.12 
The plant species was reported to be 
eaten by wild chimpanzees (Pan troglodytes 
schweinfurthii).13 The active compounds 
(acetogenins) isolated from Uvariopsis congensis 
Robyns & Ghesq. stem bark extract showed 
highly significant medicinal properties like 
antibacterial, antimalarial, and/or antileishmania.14 
However, no study has yet been reported on the 
antisickling activity of Uvariopsis congensis Robyns & 
Ghesq. stem bark extract. The plant could be 
potentially non-toxic to man and could provide 
new sources of anti-sickling compounds.  
Sickle cell disease (SCD) is a 
hemoglobinopathy which naturally occurring in 
black people. At the genetic level, SCD is 
characterized by a single base substitution in the 
gene encoding the human β-globin subunit and 
results in replacement of β6 glutamic acid by 
valine that causes an abnormal, rigid and sickle 
shape in hypoxia.15, 16  
In Democratic Republic of the Congo 
(DRC), surveys reported that 12% of the 
hospitalized children are sicklers and the annual 
cost of the treatment of SCD is higher than 
1.000,00 USD per patient.17 It is therefore 
necessary to develop innovative strategy for 
identifying new source of antisickling agents 
through zoopharmacognosy.6-11 
The aim of this study is to evaluate the 
chemical composition and bioactivity of Uvariopsis 
congensis Robyns & Ghesq. stem bark extract 
against SCD and associated bacteria, a plant 
species which has been selected through the 
animal source of knowledge (new paradigm) in 
order to discover new phytomedicine for human.  
 
Materials and Methods 
Plant identification and preparation of extracts 
The plant material (stem barks) used in 
the present study was collected in Kisangani city 
(Tshopo Province, Democratic Republic of the 
Congo) during a field work in July-August 2015 
and authenticated by Justin A. Asimonyio of the 
Biodiversity monitoring centre, University of 
Kisangani. Voucher specimen No JAA05T is on 
deposit at the Laboratory of Molecular bio-
prospection (Department of Biology, Faculty of 
Science of the Kinshasa University). 
 
Test extract preparation 
The plant material (1 kg) was kept at 
room temperature (25 to 30 °C) for air drying 
(two weeks). The air-dried and powdered material 
(50 g) was extracted by repeated maceration with 
ethanol 90° (3×4 hrs, 1.5 L) at room temperature. 
After filtering the mixture, the aqueous-ethanol 
filtrates were pooled, dried over Na2SO4 and 
evaporated to dryness under reduced pressure 
using a rotary evaporator to yield crude ethanolic 
extract. Extract was stored at 4 °C. 
 
Phytochemical screening 
The dried and powdered plant material (10 g) was 
repeatedly extracted by cold percolation with 95% 
ethanol (EtOH) and water (100 mL × 2) for 48 
hours. Chemical screening was performed on the 
aqueous and organic extracts to investigate the 
presence of alkaloids, saponins, total polyphenols, 
flavonoids, tannins, anthocyanis, leuco-
anthocyanins, quinones, terpenes and steroids 
according to standard protocol.18 
 
Detection of phenols (Ferric Chloride Test)  
Total phenolics contents were determined 
according to the Folin-Ciocalteu method with 
slight modifications.19 The extract (200 μL) was 
mixed with 1.5 mL of Folin-Ciocalteu reagent 
(previously diluted 10 times with double distilled 
water) and allowed to stand at room temperature 
for 5 min. 1.5 mL of sodium bicarbonate solution 
(60 g/L) was added to the mixture and after 
incubation for 90 min at room temperature, the 
absorbance was measured at 725 nm using a UV-
Visible spectrophotometer (GENESYS 10S). 
Total phenolic were quantified by calibration 
curve obtained from measuring the absorbance of 
the known concentrations of gallic acid standard 
solutions (10-150 μg/mL  in 80% methanol). The 
results were calculated as gallic acid equivalent 
(GAE) per one gram dry powder and reported as 
mean value ± standard deviation (SD) (the 
standard curve equation: Y= 0,006×-0,002 ; R2 = 
0,997). 
Detection of flavonoids 
Total flavonoid content was measured by the 
aluminum chloride colorimetric method. 20 An 
aliquot (1 mL) of each extract was added to 10 mL 
volumetric flask containing 4 mL of double 
distilled water. Then 0.3 mL NaNO2 5% was 
added to the flask and after 5 min, 0.3 mL AlCl3 
(10%) was also added. At 6th min, 2 mL NaOH (1 
M) was added and the total volume was made up 
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to 10 mL with double distilled water. The solution 
was mixed completely and the absorbance was 
measured versus prepared reagent blank at 510 
nm. Total flavonoid content was expressed as mg 
quercetin equivalents (QE) per one gram dry 
powder. One mL of standard solution (quercetin: 
5-100 µg/mL) was used to construct calibration 
curve (the standard curve equation: Y = 0.009× + 
0.006; R2 = 0,999). 
Detection of tannins 
To 1 ml of the extract was added 7,5 ml of 
distilled water and 0,5 ml of Folin-Ciocalteu 
reagent and 1 ml of sodium carbonate (Na2CO3 
35%). The absorbance was measured at the 
wavelength of 725 nm. The tannins content 
(expressed as tannic acid equivalent, TAE) was 
calculated using the following relation: Y = 0,443 
× - 0,264; R2 = 0,720.22 
Detection of anthocyanins 
The samples were diluted with the mixture 
ethanol/water/HCl conc. (70:30:1; v/v/v) and the 
absorbance was measured at the wavelength of 
540 nM. The anthocyanins content (expressed as 
malvidin-3-glucoside equivalent, M-3-GE) was 
calculated using the following relation: 
Anthocyanins =A540 ×(10/0.6)×d (with A540= 
maximum of absorption at 540 nm; d = dilution 
factor; 0.6 maximum of absorption of 10 mg/L of 
M-3-GE standard solution).21. 
 
Bioassays 
In vitro antisickling bioassay  
Blood samples used to assess the 
antisickling activity of the selected plant extracts 
were taken from known SCD patients attending 
the “Centre de Médecine Mixte et d’Anémie SS” 
located in Kinshasa, Democratic Republic of the 
Congo. None of the patients had been transfused 
recently with Hb AA blood and all antisickling 
experiments were carried out with freshly 
collected blood. In order to confirm their SS 
nature, the above-mentioned blood samples were 
first characterized by hemoglobin electrophoresis 
on cellulose acetate gel to confirm their status and 
were then stored at 4 °C in a refrigerator. An 
informed consent was obtained from all the 
patients participating in the study and all the 
research procedures have received the approval of 
Department of Biology Ethics Committee. 
An aliquot of Hb S-blood was diluted 
with 150 mM phosphate buffered saline 
(NaH2PO4 30 mM, Na2HPO4 120 mM, NaCl 150 
mM) and mixed with an equivalent volume of 2% 
sodium metabisulfite. A drop from the mixture 
was spotted on a microscope slide in the presence 
or absence of plant extracts and covered with a 
cover slip. Paraffin was applied to seal the edges 
of the cover completely to exclude air (Hypoxia). 
Duplicate analyses were run for each extract. The 
red blood cells (RBCs) were analyzed by a 
computer assisted image analysis software (Motic 
Images 2000, version 1.3; Motic China Group Co 
LTD) and statistical data analysis were processed 
using Microcal Origin 8.5 Pro package software as 
previously reported. 23-27 
 
Determination of antibacterial activity  
The activity of the plant extract was tested against 
Staphylococcus aureus (S. aureus ATCC 33591) 
and Escherichia coli (E. coli ATCC 27195) strains. 
The tested strains were obtained from the 
American Type Culture Collection (ATCC, 
Rockville MD, USA) 
Determination of Minimum inhibitory concentration 
(MIC)  
The Minimum inhibitory concentration 
(MIC) was determined by broth micro-dilution 
method as reported in our previously research 
work.28, 29 The inocula of used microorganisms 
were prepared from 24 hours old broth cultures. 
The absorbance was read at 600 nm and adjusted 
with sterile physiological solution (0.9% NaCl) to 
match that of a 0.5 McFarland standard solution 
(108 cells/mL). The prepared microbial 
suspension was diluted (1/100) to achieve 106 
CFU/mL. Stock solutions of the plant extracts 
were prepared in Tween 80 (Fisher chemicals) (3 
mg/300 µL) and diluted to 2.7 ml with Mueller 
Hinton Broth (MHB) (Conda, Madrid, Spain) to 
achieve a Tween 80 final concentration of 0.1%. 
This solution was transferred in 96-wells plates 
(200 µL/well) and two-fold serially diluted with 
MHB to give final concentrations ranging from 
1000 to 3,906 µg/mL. 
An aliquot (10 µL) of 106 CFU/mL 
overnight culture was added to wells of a sterile 
96-well micro-plate titer. The positive control 
wells contained both MHB and bacteria 
suspension without plant extract while negative 
control wells contained MHB only. The MIC was 
determined as the lowest plant extract 
concentration at which no growth were observed 
after 24 hours. Resasurin (30 μL) in aqueous 
solution (0.01%) was used to evaluate the micro-
organism viability. 
 
Antisickling and antibacterial activities of Uvariopsis congensis …                                                                                                                      Ngbolua et al. 
Discovery Phytomedicine 2016; 3 (2): 7-14. doi: 10.15562/phytomedicine.2016.33       www.phytomedicine.ejournals.ca 
       10 
 
Statistical analysis 
The results of in vitro study are given as 
Mean ±Standard Deviation obtained from three 
independent experiments. The results of in vivo 
study were expressed also as Mean ± Standard 
Deviation and analyzed with Student’s t-test for 
paired data using Origin version 8.5 Pro package 
software. All data were analyzed at a 95% 
confidence interval (α= 0.05). 
 
Results and Discussion 
Extract yields and chemical screening 
The phytochemical analyses performed 
on Uvariopsis congensis Robyns & Ghesq. stem bark 
extract revealed the presence of alkaloids, 
saponins, total polyphenols (87.942±0.536 µg 
GAE/g), flavonoids (0.623±0.630 µg QE/g), 
tannins (0889±0.002 µg TAE/g), anthocyanis 
(0.150±0.017 µg M-3GE/g), leuco-anthocyanins, 
quinones, terpenes and steroids. Phenolic 
compounds such as anthocyanins3, 9, 16, 23-27, 31-33 
rosmarinic acid34 and lunularic acid35 and 
triterpenes like betulinic, maslinic, oleanolic36 and 
ursolic acid37 were reported to display antisickling 
activity in vitro.  
Antisickling acctivity  
The figure 1 give the morphology of 
untreated sickle erythrocytes (SE) and SE treated 
with Uvariopsis congensis Robyns & Ghesq. stem 
bark extract.  
 
 
 
 
 
                                                         (a) Untreated SS RBCs (control)         (b) SS RBCs + EtOH extract 
    
 
Figure 1. Morphology of untreated sickle erythrocytes (a) and 
SE treated with 50 µg/mL of Uvariopsis congensis (b) (X500), [NaCl 0.9%; Na2S2O5 2%]. 
 
 
 
Cell parameters Untreated SE SE + EtOH 
Radius (µm) 0.00±0.00 3.5±0.4 
Perimeter (µm) 36.0±1.5 19.2±1.1 
Area (µm2) 21.4±1.3 34.6±1.2 
 
                                     Table 1. Average values of radius, perimeter and surface of untreated and sickle erythrocytes (SE) 
treated with ethanolic extract of Uvariopsis congensis. 
 
Figure 1a revealed that the control contains in 
majority sickle-shaped erythrocytes, confirming 
the homozygous (SS) nature of the blood. Mixed 
together with ethanolic extract (Figure 1b), the 
majority of erythrocytes are reversed normal-
shape. This indicates that Uvariopsis congensis 
Robyns & Ghesq. stem bark extract have 
antisickling effect. Our previous research works 
revealed that this activity could be due to 
compounds such as anthocyanins, phenolic or 
triterpenoic acids.3, 9, 16, 23-27, 30-37 The treated SE 
demonstrated a remarkable similarity to normal 
red blood cells.  
The table 1 gives the average values of cell 
parameters (radius, perimeter and area) of 
untreated and sickle erythrocytes treated with the 
extract of Uvariopsis congensis.  
Table 1 indicates that untreated sickle 
cells are not circular, so it’s not possible to 
calculate the radius due to their sickled shape in 
hypoxic conditions. While, in the presence of 
plant extract; drepanocyte recovered normal 
shape.  
This phenomenon is confirmed by the 
appearance of radius, the increase of the treated 
cell area and the decrease of it perimeter if 
compared to untreated sickle erythrocyte 
(p<0.05). Indeed, the computer software package 
(Motic Images 2000 version 1.3) used in this study 
did not give the average radius for untreated sickle 
Antisickling and antibacterial activities of Uvariopsis congensis …                                                                                                                      Ngbolua et al. 
 
Discovery Phytomedicine 2016; 3 (2): 7-13. doi: 10.15562/phytomedicine.2016.33       www.phytomedicine.ejournals.ca 
 
11 
20 40 60 80 100
30
40
50
60
70
80
90
S
ic
k
le
 e
ry
th
ro
cy
te
s 
n
o
rm
al
iz
at
io
n
 (
%
)
EtOH extract concentration (µg/mL)
 
 
 
Figure 2. Dose-dependent normalization of sickle erythrocytes treated with extract from Uvariopsis congensis 
 
 
cells, as sickled cells of untreated blood were not 
circular. The average radius appeared after 
treatment of sickle cells with ethanolic extract of 
Uvariopsis congensis is an indication of the bioactivity 
of this plant species. 
The normalization rate of sickled cells 
increases with the extract concentration and 
reached a maximum and constant value at 100 
µg/mL (minimal concentration of normalization, 
MCN). This corresponds to a normalization rate 
of 89% with an ED50 (dose of extract for which 
50% of the sickled erythrocytes are reversed) equal 
to 0.6 µg/ml. Thus, the antisickling activity of 
Uvariopsis congensis is dose dependent (figure 2). 
The extracts from Uvariopsis congensis, because of 
their bioactive secondary metabolites richness like 
phenolic compounds (anthocyanins), could exert 
the antisickling effect through various 
mechanisms like the inhibition of free radicals 
formation, the inhibition of hemoglobin 
polymerization, and the inhibition of erythrocyte 
hemolysis.   
 
Antibacterial activity 
Due to the high cost of modern therapy 
for SCD, a medicinal plant species displaying at 
the same time antisickling and antibacterial 
activities could be useful in the management of 
this disease. The antibacterial activity of Uvariopsis 
congensis Robyns & Ghesq. stem bark extract was 
evaluated against E. coli and S. aureus strains.   
Results revealed that the negative 
bacterium E. coli was more sensitive to plant 
extact (MIC=250 µg/mL) than S. aureus 
(MIC=500 µg/mL). This antibacterial activity is 
however weak if compared to the MIC reference 
value of 100 µg/mL. Indeed, a value lower or 
equal to 100 indicates a great antibacterial activity. 
8 The difference in the bioactivity would be due to 
the nature of the bacterial wall. 38 These results 
are in agreement with previous works on the 
antimicrobial activity of natural products of plant 
origin. 28, 29  It was reported that S. aureus and E 
coli constitute both the principal bacteria 
responsible for septicemia and the osteomyelitis in 
SCD patients. 39 To this end, Uvariopsis congensis is 
a better candidate for the development of 
phytomedicine with broad spectrum of action for 
the management of SCD. The antibacterial activity 
observed in this study can be improved through 
liquid-liquid extraction and chromatographic bio-
guided fractionation of the ethanolic extract. To 
our knowledge, it is for the first time that the 
antisickling activity of Uvariopsis congensis is 
reported in the literature.   
 
Conclusions 
The present study evaluated the chemical 
composition and the antisickling and antibacterial 
activities of Uvariopsis congensis Robyns & Ghesq. 
stem bark extract. The results revealed that: The 
stem bark of Uvariopsis congensis contains various 
secondary metabolites such as the anthocyanins, 
flavonoids, tannins, quinones, saponins, alkaloids, 
steroids, terpenoids and leuco-anthocyanins; 
Ethanolic extracts displayed very interesting 
antisickling activity in vitro (ED50= 0.6 µg/mL). 
These extracts could exert their antisickling effect 
through various mechanisms including the 
inhibition of free radicals formation, the inhibition 
of hemoglobin polymerization, and the inhibition 
of erythrocyte hemolysis. The minimum inhibitory 
concentrations (MIC) were 250 µg/mL and 500 
µg/mL respectively for E. coli ATCC 27195 and 
S. aureus ATCC 33591.  
This study provided experimental 
evidence that supports further development of 
Uvariopsis congensis extracts as a medicine for the 
management of SCD in the Congo basin. The 
animal self-medication constitutes thus an 
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innovative method which could lead to the 
discovery of new drugs for the treatment of 
human ailments. 
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